Diffusion MR of acute stroke

Acute Ischemic Stroke: Imaging and Intervention

Volumn , Issue , 2006, Pages 145-174

  Kim, Anne Catherine ^a   Kiruluta, A ^a   Gilberto Gonzalez R ^a   Schaefer, Pamela W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864248389     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-12751-9_7     Document Type: Chapter

References (142)

1. Cooper, R., et al., Restricted diffusion in biophysical systems. Exp Biophys J, 1974. 14(3): p. 161-177.
2. Basser, P. J. and C. Pierpaoli, Microstructural and physiological features of tissues elucidated by quantitative-diffusiontensor MRI. J Magn Reson B, 1996. 111(3): p. 209-19.
3. Sevick, R. J., et al., Cytotoxic brain edema: assessment with diffusion-weighted MR imaging. Radiology, 1992. 185(3): p. 687-90.
4. Mintorovitch, J., et al., Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na+, K (+)-ATPase activity. J Cereb Blood Flow Metab, 1994. 14(2): p. 332-6.
5. Benveniste, H., L. W. Hedlund, and G. A. Johnson, Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke, 1992. 23(5): p. 746-54.
6. Niendorf, T., et al., Biexponential diffusion attenuation in various states of brain tissue: implications for diffusion-weighted imaging. Magn Reson Med, 1996. 36(6): p. 847-57.
7. Sykova, E., et al., Extracellular volume fraction and diffusion characteristics during progressive ischemia and terminal anoxia in the spinal cord of the rat. J Cereb Blood Flow Metab, 1994. 14(2): p. 301-11.
8. Wick, M., et al., Alteration of intracellular metabolite diffusion in rat brain in vivo during ischemia and reperfusion. Stroke, 1995. 26(10): p. 1930-3; discussion 1934.
9. van der Toorn, A., et al., Diffusion of metabolites in normal and ischemic rat brain measured by localized 1H MRS. Magn Reson Med, 1996. 36(6): p. 914-22.
10. Duong, T. Q., et al., Evaluation of extra- and intracellular apparent diffusion in normal and globally ischemic rat brain via 19F NMR. Magn Reson Med, 1998. 40(1): p. 1-13.
11. Morikawa, E., et al., The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab, 1992. 12(3): p. 380-9.
12. Le Bihan, D., J. Delannoy, and R. L. Levin, Temperature mapping with MR imaging of molecular diffusion: application to hyperthermia. Radiology, 1989. 171(3): p. 853-7.
13. Szafer, A., J. Zhong, and J. C. Gore, Theoretical model for water diffusion in tissues. Magn Reson Med, 1995. 33(5): p. 697-712.
14. Helpern, J., R. Ordidige, and R. Knight. The effect of cell membrane water permeability on the apparent diffusion of water,. in SMRM. 1992. Berlin.
15. Kucharczyk, J., et al., Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology, 1993. 188(3): p. 711-7.
16. Matsumoto, K., et al., Role of vasogenic edema and tissue cavitation in ischemic evolution on diffusion-weighted imaging: comparison with multiparameter MR and immunohistochemistry. AJNR Am J Neuroradiol, 1995. 16(5): p. 1107-15.
17. Kucharczyk, J., et al., Diffusion/perfusion MR imaging of acute cerebral ischemia. Magn Reson Med, 1991. 19(2): p. 311-5.
18. Moseley, M. E., et al., Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med, 1990. 14(2): p. 330-46.
19. Moseley, M. E., et al., Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol, 1990. 11(3): p. 423-9.
20. Mintorovitch, J., et al., Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med, 1991. 18(1): p. 39-50.
21. Moonen, C. T., et al., Restricted and anisotropic displacement of water in healthy cat brain and in stroke studied by NMR diffusion imaging. Magn Reson Med, 1991. 19(2): p. 327-32.
22. Warach, S., et al., Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol, 1995. 37(2): p. 231-41.
23. Schlaug, G., et al., Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology, 1997. 49(1): p. 113-9.
24. Lutsep, H. L., et al., Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol, 1997. 41(5): p. 574-80.
25. Schwamm, L. H., et al., Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke, 1998. 29(11): p. 2268-76.
26. Hjort, N., et al., Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann Neurol, 2005. 58(3): p. 462-5.
27. Copen, W. A., et al., Ischemic stroke: effects of etiology and patient age on the time course of the core apparent diffusion coefficient. Radiology, 2001. 221(1): p. 27-34.
28. Marks, M. P., et al., Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology, 1999. 52(9): p. 1792-8.
29. Nagesh, V., et al., Time course of ADCw changes in ischemic stroke: beyond the human eye! Stroke, 1998. 29(9): p. 1778-82.
30. Gonzalez, R. G., et al., Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology, 1999. 210(1): p. 155-62.
31. Mohr, J., et al., Magnetic resonance versus computed tomographic imaging in acute stroke. Stroke, 1995. 26: p. 807-12.
32. Bryan, R., et al., Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol, 1991. 12: p. 611-20.
33. Lovblad, K. O., et al., Clinical experience with diffusionweighted MR in patients with acute stroke. AJNR Am J Neuroradiol, 1998. 19(6): p. 1061-6.
34. Mullins, M. E., et al., CT and conventional and diffusionweighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology, 2002. 224(2): p. 353-60.
35. Marks, M. P., et al., Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology, 1996. 199(2): p. 403-8.
36. Ay, H., et al., Normal diffusion-weighted MRI during stroke-like deficits. Neurology, 1999. 52(9): p. 1784-92.
37. Schaefer, P. W., P. E. Grant, and R. G. Gonzalez, Diffusionweighted MR imaging of the brain. Radiology, 2000. 217(2): p. 331-45.
38. Singer, M. B., et al., Diffusion-weighted MRI in acute subcortical infarction. Stroke, 1998. 29(1): p. 133-6.
39. Kuhl, C. K., et al., Acute and subacute ischemic stroke at high-field-strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study. Radiology, 2005. 234(2): p. 509-16.
40. Grant, P. E., et al., Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology, 2001. 221(1): p. 43-50.
41. Olivot, J. M., et al., Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke, 2009. 40(5): p. 1692-7.
42. Kidwell, C. S., et al., Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol, 2002. 52(6): p. 698-703.
43. Schaefer, P. W., et al., Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol, 2002. 23(10): p. 1785-94.
44. Fiehler, J., et al., Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke, 2004. 35(2): p. 514-9.
45. Fiehler, J. et al. Apparent diffusion coefficient decreases and magnetic resonance imaging perfusion parameters are associated in ischemic tissue of acute stroke patients. J Cereb Blood Flow Metab, 2001. 21(5): p. 577-84.
46. Jones, T. H., et al., Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg, 1981. 54(6): p. 773-82.
47. Horowitz, S. H., et al., Computed tomographic-angiographic findings within the first five hours of cerebral infarction. Stroke, 1991. 22(10): p. 1245-53.
48. Hornig, C. R., W. Dorndorf, and A. L. Agnoli, Hemorrhagic cerebral infarction-a prospective study. Stroke, 1986. 17(2): p. 179-85.
49. Hakim, A. M., A. Ryder-Cooke, and D. Melanson, Sequential computerized tomographic appearance of strokes. Stroke, 1983. 14(6): p. 893-7.
50. Calandre, L., J. F. Ortega, and F. Bermejo, Anticoagulation and hemorrhagic infarction in cerebral embolism secondary to rheumatic heart disease. Arch Neurol, 1984. 41(11): p. 1152-4.
51. Selim, M., et al., Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke, 2002. 33(8): p. 2047-52.
52. Tong, D. C., et al., Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging. Arch Neurol, 2001. 58(4): p. 587-93.
53. Oppenheim, C., et al., DWI prediction of symptomatic hemorrhagic transformation in acute MCA infarct. J Neuroradiol, 2002. 29(1): p. 6-13.
54. Campbell, B. C., et al., Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke, 2010. 41(1): p. 82-8.
55. Vo, K. D., et al., MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke. AJNR Am J Neuroradiol, 2003. 24(4): p. 674-9.
56. *-weighted MRI: a marker of hemorrhagic transformation risk in patients treated with intravenous tissue plasminogen activator. J Cereb Blood Flow Metab, 2003. 23(11): p. 1362-70.
57. Schaefer, P. W., et al. Assessing hemorrhagic transformation with diffusion and perfusion MR imaging. in 41st annual meeting of the American Society of Neuroradiology. 2003. Washington, DC.
58. Kassner, A., et al., Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. AJNR Am J Neuroradiol, 2005. 26(9): p. 2213-7.
59. Neumann-Haefelin, T., et al., Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke, 2006. 37(10): p. 2463-6.
60. Lansberg, M. G., et al., Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke, 2007. 38(8): p. 2275-8.
61. Le Bihan, D., et al., Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging, 2001. 13(4): p. 534-46.
62. Shimony, J. S., et al., Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis. Radiology, 1999. 212(3): p. 770-84.
63. Bammer, R., B. Acar, and M. E. Moseley, In vivo MR tractography using diffusion imaging. Eur J Radiol, 2003. 45(3): p. 223-34.
64. Conturo, T. E., et al., Tracking neuronal fiber pathways in the living human brain. Proc Natl Acad Sci U S A, 1999. 96(18): p. 10422-7.
65. Makris, N., et al., Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging. Ann Neurol, 1997. 42(6): p. 951-62.
66. Mukherjee, P., et al., Differences between gray matter and white matter water diffusion in stroke: diffusion-tensor MR imaging in 12 patients. Radiology, 2000. 215(1): p. 211-20.
67. Sorensen, A. G., et al., Human acute cerebral ischemia: detection of changes in water diffusion anisotropy by using MR imaging. Radiology, 1999. 212(3): p. 785-92.
68. Pierpaoli, C., et al., Diffusion tensor MR imaging of the human brain. Radiology, 1996. 201(3): p. 637-48.
69. Reese, T. G., et al., Imaging myocardial fber architecture in vivo with magnetic resonance. Magn Reson Med, 1995. 34(6): p. 786-91.
70. Moseley, M. E., et al., Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology, 1990. 176(2): p. 439-45.
71. Moseley, M. E., et al., Anisotropy in diffusion-weighted MRI. Magn Reson Med, 1991. 19(2): p. 321-6.
72. Le Bihan, D. and P. van Zijl, From the diffusion coefficient to the diffusion tensor. NMR Biomed, 2002. 15(7-8): p. 431-4.
73. Beaulieu, C., The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed, 2002. 15(7-8): p. 435-55.
74. Zelaya, F., et al., An evaluation of the time dependence of the anisotropy of the water diffusion tensor in acute human ischemia. Magn Reson Imaging, 1999. 17(3): p. 331-48.
75. Yang, Q., et al., Serial study of apparent diffusion coeffcient and anisotropy in patients with acute stroke. Stroke, 1999. 30(11): p. 2382-90.
76. Ozsunar, Y., et al., Evolution of water diffusion and anisotropy in hyperacute stroke: significant correlation between fractional anisotropy and T2. AJNR Am J Neuroradiol, 2004. 25(5): p. 699-705.
77. Higano, S., et al., Diffusion anisotropy of the internal capsule and the corona radiata in association with stroke and tumors as measured by diffusion-weighted MR imaging. AJNR Am J Neuroradiol, 2001. 22(3): p. 456-63.
78. Watanabe, T., et al., Three-dimensional anisotropy contrast magnetic resonance axonography to predict the prognosis for motor function in patients suffering from stroke. J Neurosurg, 2001. 94(6): p. 955-60.
79. Werring, D. J., et al., Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke. J Neurol Neurosurg Psychiatry, 2000. 69(2): p. 269-72.
80. Lovblad, K. O., et al., Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol, 1997. 42(2): p. 164-70.
81. Beaulieu, C., de Crespingy, A., Tong, D. C., Moseley, M. E., Albers, G. W., Marks, M. P., Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol, 1999. 46(4): p. 568-78.
82. Nighoghossian, N., et al., Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke, 2003. 34(2): p. 458-63.
83. van Everdingen, K. J., et al., Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke, 1998. 29(9): p. 1783-90.
84. Tong, D. C., et al., Correlation of perfusion- and diffusionweighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology, 1998. 50(4): p. 864-70.
85. Engelter, S., et al., Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke. Cerebrovasc Dis, 2003. 15(3): p. 188-91.
86. Rohl, L., et al., Correlation between diffusion- and perfusion-weighted MRI and neurological deficit measured by the Scandinavian Stroke Scale and Barthel Index in hyperacute subcortical stroke (< or = 6 hours). Cerebrovasc Dis, 2001. 12(3): p. 203-13.
87. Thijs, V., et al., Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke, 2000. 31(11): p. 2597-602.
88. Engelter, S., et al., The clinical significance of diffusionweighted MR imaging in infratentorial strokes. Neurology, 2004. 62(4): p. 474-80.
89. Arenillas, J. F., et al., Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke, 2002. 33(9): p. 2197-203.
90. Yoo, A. J., Verduzco, V. L., Schaefer, P. W., Hirsch, J. A., Rabinov, J. D., González, R. G., MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke, 2009. 40(6): p. 2046-54.
91. Sibon, I., et al., Inter- and intraobserver reliability of five MRI sequences in the evaluation of the final volume of cerebral infarct. J Magn Reson Imaging, 2009. 29(6): p. 1280-4.
92. Easton, J. D., et al., Defnition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affrms the value of this statement as an educational tool for neurologists. Stroke, 2009. 40(6): p. 2276-93.
93. Ay, H., et al., 'Footprints' of transient ischemic attacks: a diffusion-weighted MRI study. Cerebrovasc Dis, 2002. 14(3-4): p. 177-86.
94. Kidwell, C. S., et al., Diffusion MRI in patients with transient ischemic attacks. Stroke, 1999. 30(6): p. 1174-80.
95. Purroy, F., et al., Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute lesions. Stroke, 2004. 35: p. 3213-9.
96. Crisostomo, R., M. Garcia, and D. Tong, Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation wsith clinical characteristics. Stroke, 2003. 34(4): p. 932-7.
97. Inatomi, Y., et al., DWI abnormalities and clinical characteristics in TIA patients. Neurology, 2004. 62(3): p. 376-80.
98. Ay, H., et al., Transient ischemic attack with infarction: a unique syndrome? Ann Neurol, 2005. 57(5): p. 679-86.
99. Huber, R., et al., Transient Global Amnesia. Evidence against vascular ischemic etiology from diffusion weighted imaging. J Neurol, 2002. 249(11): p. 1520-4.
100. Saito, K., et al., Transient global amnesia associated with an acute infarction in the retrosplenium of the corpus callosum. J Neurol Sci, 2003. 210(1-2): p. 95-7.
101. Matsui, M., et al., Transient global amnesia: increased signal intensity in the right hippocampus on diffusion-weighted magnetic resonance imaging. Neuroradiology, 2002. 44(3): p. 235-8.
102. Ay, H., et al., Diffusion-weighted MRI characterizes the ischemic lesion in transient global amnesia. Neurology, 1998. 51(3): p. 901-3.
103. Greer, D. M., P. W. Schaefer, and L. H. Schwamm, Unilateral temporal lobe stroke causing ischemic transient global amnesia: role for diffusion-weighted imaging in the initial evaluation. J Neuroimaging, 2001. 11(3): p. 317-9.
104. Woolfenden, A. R., et al., Diffusion-weighted MRI in transient global amnesia precipitated by cerebral angiography. Stroke, 1997. 28(11): p. 2311-4.
105. Sedlaczek, O., et al., Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology, 2004. 62(12): p. 2165-70.
106. Sloviter, R. S. and D. W. Dempster, "Epileptic" brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res Bull, 1985. 15(1): p. 39-60.
107. Olney, J. W., Excitatory transmitters and epilepsy-related brain damage. Int Rev Neurobiol, 1985. 27: p. 337-62.
108. McNamara, J. O., Cellular and molecular basis of epilepsy. J Neurosci, 1994. 14(6): p. 3413-25.
109. Jacob, A., et al., Imaging abnormalities in sporadic hemiplegic migraine on conventional MRI, diffusion and perfusion MRI and MRS. Cephalalgia, 2006. 26(8): p. 1004-9.
110. Butteriss, D. J., V. Ramesh, and D. Birchall, Serial MRI in a case of familial hemiplegic migraine. Neuroradiology, 2003. 45(5): p. 300-3.
111. Gutschalk, A., et al., Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine. Neurosci Lett, 2002. 332(2): p. 115-8.
112. Chabriat, H., et al., Decreased hemispheric water mobility in hemiplegic migraine related to mutation of CACNA1A gene. Neurology, 2000. 54(2): p. 510-2.
113. Kim, J. H., et al., Reversible splenial abnormality in hypoglycemic encephalopathy. Neuroradiology, 2007. 49: p. 217-22
114. Yanagawa, Y., et al., Diffusion-weighted MRI predicts prognosis in severe hypoglycemic encephalopathy. J Clin Neurosci, 2006. 13(6): p. 696-9.
115. Kim, S. Y., et al., Neonatal hypoglycaemic encephalopathy: diffusion-weighted imaging and proton MR spectroscopy. Pediatr Radiol, 2006. 36(2): p. 144-8.
116. Maekawa, S., et al., Time related changes in reversible MRI fndings after prolonged hypoglycemia. Clin Neurol Neurosurg, 2006. 108(5): p. 511-3.
117. Ebisu, T., et al., Discrimination between different types of white matter edema with diffusion-weighted MR imaging. J Magn Reson Imaging, 1993. 3: p. 863-8.
118. Schaefer, P. W., et al., Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke, 1997. 28(5): p. 1082-5.
119. Schwartz, R. B., et al., Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol, 1998. 19(5): p. 859-62.
120. Nakazato, T., et al., Reversible posterior leukoencephalopathy syndrome associated with tacrolimus therapy. Intern Med, 2003. 42(7): p. 624-5.
121. Henderson, R. D., et al., Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology, 2003. 60(2): p. 326-8.
122. Sylvester, S. L., et al., Reversible posterior leukoencephalopathy in an HIV-infected patient with thrombotic thrombocytopenic purpura. Scand J Infect Dis, 2002. 34(9): p. 706-9.
123. Utz, N., et al., MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome. Neuroradiology, 2001. 43(12): p. 1059-62.
124. Edwards, M. J., et al., Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol, 2001. 12(9): p. 1327-9.
125. Soylu, A., et al., Posterior leukoencephalopathy syndrome in poststreptococcal acute glomerulonephritis. Pediatr Nephrol, 2001. 16(7): p. 601-3.
126. Ikeda, M., et al., Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis, 2001. 37(4): p. E30.
127. Kamar, N., et al., Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients. Am J Kidney Dis, 2001. 37(4): p. E29.
128. Honkaniemi, J., et al., Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology, 2000. 42(12): p. 895-9.
129. Taylor, M. B., A. Jackson, and J. M. Weller, Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated with haemolytic uraemic syndrome. Br J Radiol, 2000. 73(868): p. 438-42.
130. Lewis, M. B., Cyclosporin neurotoxicity after chemotherapy. Cyclosporin causes reversible posterior leukoencephalopathy syndrome. BMJ, 1999. 319(7201): p. 54-5.
131. Ito, Y., et al., Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol, 1998. 19(3): p. 415-7.
132. Bartynski, W. S., Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol, 2008. 29(6): p. 1036-42.
133. Covarrubias, D. J., P. H. Luetmer, and N. G. Campeau, Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol, 2002. 23(6): p. 1038-48.
134. Bartynski, W. S., Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol, 2008. 29(6): p. 1043-9.
135. Breen, J. C., et al., Brain edema after carotid surgery. Neurology, 1996. 46(1): p. 175-81.
136. Kuroda, H., et al., Prediction of cerebral hyperperfusion after carotid endarterectomy using middle cerebral artery signal intensity in preoperative single-slab 3-dimensional timeof-flight magnetic resonance angiography. Neurosurgery, 2009. 64(6): p. 1065-71; discussion 1071-2.
137. Tan, G. S. and C. C. Phatouros, Cerebral hyperperfusion syndrome post-carotid artery stenting. J Med Imaging Radiat Oncol, 2009. 53(1): p. 81-6.
138. Bentley, J. N., R. E. Figueroa, and J. R. Vender, From presentation to follow-up: diagnosis and treatment of cerebral venous thrombosis. Neurosurg Focus, 2009. 27(5): p. E4.
139. Filippidis, A., et al., Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus, 2009. 27(5): p. E3.
140. Smith, W. H., S. L., Hauser, D. J., Easton, Cerebrovascular Disease, in Harrison's Principles of Internal Medicine, F. A. Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Editor. 2001, McGraw-Hill: New York. p. 2369-91.
141. Mullins, M. E., et al., Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging. AJNR Am J Neuroradiol, 2004. 25(10): p. 1666-75.
142. Stejskal, E. and J. Tanner, Spin diffusion measurements: spin echos in the presence of time-dependent field gradient. J Chem Phys, 1965. 42: p. 288-92.